MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 41 filers reported holding MEI PHARMA INC in Q2 2015. The put-call ratio across all filers is 3.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $19,000 | -17.4% | 13,316 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $23,000 | +27.8% | 13,316 | 0.0% | 0.01% | +28.6% |
| Q2 2016 | $18,000 | +5.9% | 13,316 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $17,000 | -19.0% | 13,316 | 0.0% | 0.01% | -20.0% |
| Q4 2015 | $21,000 | -12.5% | 13,316 | -13.5% | 0.01% | -16.7% |
| Q3 2015 | $24,000 | -7.7% | 15,399 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $26,000 | -7.1% | 15,399 | 0.0% | 0.01% | -7.7% |
| Q1 2015 | $28,000 | -57.6% | 15,399 | 0.0% | 0.01% | -60.6% |
| Q4 2014 | $66,000 | -25.8% | 15,399 | +19.4% | 0.03% | -31.2% |
| Q3 2014 | $89,000 | +8.5% | 12,899 | +0.0% | 0.05% | +11.6% |
| Q2 2014 | $82,000 | -44.6% | 12,896 | -2.7% | 0.04% | -50.6% |
| Q1 2014 | $148,000 | +39.6% | 13,253 | 0.0% | 0.09% | +24.3% |
| Q4 2013 | $106,000 | -40.8% | 13,253 | -16.8% | 0.07% | -45.7% |
| Q3 2013 | $179,000 | +57.0% | 15,931 | 0.0% | 0.13% | +55.4% |
| Q2 2013 | $114,000 | – | 15,931 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |